Literature DB >> 19725128

Mesomelic dysplasia with acral synostoses Verloes-David-Pfeiffer type: follow-up study documents progressive clinical course.

Bertrand Isidor1, Antoine Hamel, Frank Plasschaert, Lieve Claus, Jacques-Marie Mercier, Geert R Mortier, Jules G Leroy, Alain Verloes, Albert David.   

Abstract

Verloes-David-Pfeiffer mesomelia-synostoses syndrome is an autosomal-dominant form of mesomelic dysplasia comprising typical acral synostoses combined with ptosis, hypertelorism, palatal abnormality, CHD, and ureteral anomalies. Since the original reports in 1995, two other patients have been described with this syndrome, one of them the patient reported in 1998 by Day-Salvatore. In this article, we report on the follow-up of some of the original cases and review the literature. We confirm that the Verloes-David-Pfeiffer syndrome (VDPS) is a progressive skeletal disorder that despite repeated corrective surgical intervention leads to severe limb deformities. No mutations were detected in the FLNB gene. To date, the cause and the pathogenesis of VDPS remain unknown. The latter is characterized in this study as a syndromic type of skeletal dysplasia because besides congenital malformations and multiple acromelic synostoses arising prenatally, VDPS manifests in postnatal life as a severe osteochondrodysplasia.

Entities:  

Mesh:

Year:  2009        PMID: 19725128     DOI: 10.1002/ajmg.a.32926

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13.

Authors:  Bertrand Isidor; Olivier Pichon; Richard Redon; Debra Day-Salvatore; Antoine Hamel; Karolina A Siwicka; Maria Bitner-Glindzicz; Dominique Heymann; Lena Kjellén; Cornelia Kraus; Jules G Leroy; Geert R Mortier; Anita Rauch; Alain Verloes; Albert David; Cédric Le Caignec
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

Review 2.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.